ABBOTT INDIA LIMITED
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2010-10-21
- Lead Sponsor
- Abbott
- Target Recruit Count
- 32
- Registration Number
- NCT00890318
- Locations
- 🇺🇸
Abbott Clinical Pharmaceutical Research Unit, Waukegan, Illinois, United States
Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer
- First Posted Date
- 2009-04-24
- Last Posted Date
- 2012-05-22
- Lead Sponsor
- Abbott
- Target Recruit Count
- 41
- Registration Number
- NCT00888108
- Locations
- 🇺🇸
Site Reference ID/Investigator# 43962, Baltimore, Maryland, United States
🇺🇸Site Reference ID/Investigator# 51982, Scottsdale, Arizona, United States
🇳🇱Site Reference ID/Investigator# 20042, Rotterdam, Netherlands
A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2009-03-27
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- Abbott
- Target Recruit Count
- 334
- Registration Number
- NCT00870467
- Locations
- 🇯🇵
Site Reference ID/Investigator# 46855, Nagano, Japan
🇯🇵Site Reference ID/Investigator# 46858, Nagoya, Japan
🇯🇵Site Reference ID/Investigator# 46860, Nagoya, Japan
Phase 1 BA Study, Single Center With Healthy Volunteers
- First Posted Date
- 2009-03-27
- Last Posted Date
- 2010-11-07
- Lead Sponsor
- Abbott
- Target Recruit Count
- 75
- Registration Number
- NCT00870948
- Locations
- 🇺🇸
Site Reference ID/Investigator # 16001, Evansville, Indiana, United States
A Safety and Tolerability Study of ABT-126 in Elderly
- First Posted Date
- 2009-03-23
- Last Posted Date
- 2010-11-02
- Lead Sponsor
- Abbott
- Target Recruit Count
- 30
- Registration Number
- NCT00867399
- Locations
- 🇺🇸
Site Reference ID/Investigator# 17283, Orlando, Florida, United States
A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects
- First Posted Date
- 2009-03-03
- Last Posted Date
- 2010-11-02
- Lead Sponsor
- Abbott
- Target Recruit Count
- 36
- Registration Number
- NCT00854659
- Locations
- 🇺🇸
Site Reference ID/Investigator# 18101, Austin, Texas, United States
Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules
- First Posted Date
- 2009-02-09
- Last Posted Date
- 2010-10-15
- Lead Sponsor
- Abbott
- Target Recruit Count
- 32
- Registration Number
- NCT00839293
- Locations
- 🇺🇸
Site Reference ID/Investigator# 16862, Waukegan, Illinois, United States
Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Venous Insufficiency
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2009-02-04
- Lead Sponsor
- Abbott
- Target Recruit Count
- 216
- Registration Number
- NCT00835822
A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2011-09-02
- Lead Sponsor
- Abbott
- Target Recruit Count
- 63
- Registration Number
- NCT00809510
- Locations
- 🇺🇸
Site Reference ID/Investigator# 16508, Delray Beach, Florida, United States
🇺🇸Site Reference ID/Investigator# 16521, Santa Monica, California, United States
🇺🇸Site Reference ID/Investigator# 16532, New York, New York, United States
Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain
- First Posted Date
- 2008-11-11
- Last Posted Date
- 2010-11-02
- Lead Sponsor
- Abbott
- Target Recruit Count
- 11
- Registration Number
- NCT00788801
- Locations
- 🇨🇦
Site Reference ID/Investigator# 13961, Toronto, Ontario, Canada
🇨🇦Site Reference ID/Investigator# 12201, Toronto, Ontario, Canada